Monitored daily ambulatory activity, inflammation, and oxidative stress in patients with claudication

Angiology

Volumn 65, Issue 6, 2014, Pages 491-496

  Gardner, Andrew W ^a,b   Parker, Donald E ^c   Montgomery, Polly S ^a   Blevins, Steve M ^d   Teague, April M ^c   Casanegra, Ana I ^d  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

C reactive protein; claudication; oxidized low density lipoprotein; peripheral artery disease

Indexed keywords

C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OXIDIZED LOW DENSITY LIPOPROTEIN; VASCULAR CELL ADHESION MOLECULE 1; BIOLOGICAL MARKER; LOW DENSITY LIPOPROTEIN;

AGED; ARTICLE; CLAUDICATION; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MOBILIZATION; OXIDATIVE STRESS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; TREADMILL EXERCISE; BLOOD; EXERCISE TEST; GAIT; INTERMITTENT CLAUDICATION; PATHOPHYSIOLOGY; PHYSIOLOGY; WALKING;

AGED; BIOMARKERS; C-REACTIVE PROTEIN; EXERCISE TEST; FEMALE; GAIT; HUMANS; INFLAMMATION; INTERMITTENT CLAUDICATION; LIPOPROTEINS, LDL; MALE; OXIDATIVE STRESS; PERIPHERAL ARTERIAL DISEASE; VASCULAR CELL ADHESION MOLECULE-1; WALKING;

EID: 84902199688     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319713489769     Document Type: Article

References (29)

1. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006 ; 113 (11). e463 - e654
2. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007 ; 45 (suppl S). S5 - S67
3. Brass EP, Hiatt WR. Review of mortality and cardiovascular event rates in patients enrolled in clinical trials for claudication therapies. Vasc Med. 2006 ; 11 (3). 141-145
4. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992 ; 326 (6). 381-386
5. Gardner AW, Skinner JS, Cantwell BW, Smith LK. Progressive vs single-stage treadmill tests for evaluation of claudication. Med Sci Sports Exerc. 1991 ; 23 (4). 402-408
6. Hiatt WR, Nawaz D, Regensteiner JG, Hossack KF. The evaluation of exercise performance in patients with peripheral vascular disease. J Cardiopulmonary Rehabil. 1988 ; 8 (12). 525-532
7. McDermott MM, Greenland P, Liu K, et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA. 2001 ; 286 (13). 1599-1606
8. McDermott MM, Liu K, Greenland P, et al. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA. 2004 ; 292 (4). 453-461
9. McDermott MM, Liu K, O'Brien E, et al. Measuring physical activity in peripheral arterial disease: a comparison of two physical activity questionnaires with an accelerometer. Angiology. 2000 ; 51 (2). 91-100
10. Sieminski DJ, Gardner AW. The relationship between free-living daily physical activity and the severity of peripheral arterial occlusive disease. Vasc Med. 1997 ; 2 (4). 286-291
11. Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA. 1995 ; 274 (12). 975-980
12. Hickman P, Harrison DK, Hill A, et al. Exercise in patients with intermittent claudication results in the generation of oxygen derived free radicals and endothelial damage. Adv Exp Med Biol. 1994 ; 361: 565-570
13. Khaira HS, Maxwell SR, Shearman CP. Antioxidant consumption during exercise in intermittent claudication. Br J Surg. 1995 ; 82 (12). 1660-1662
14. Silvestro A, Scopacasa F, Oliva G, de Cristofaro T, Iuliano L, Brevetti G. Vitamin C prevents endothelial dysfunction induced by acute exercise in patients with intermittent claudication. Atherosclerosis. 2002 ; 165 (2). 277-283
15. Turton EP, Coughlin PA, Kester RC, Scott DJ. Exercise training reduces the acute inflammatory response associated with claudication. Eur J Vasc Endovasc Surg. 2002 ; 23 (4). 309-316
16. Pipinos II, Judge AR, Selsby JT, et al. The myopathy of peripheral arterial occlusive disease: part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction. Vasc Endovascular Surg. 2007 ; 41 (6). 481-489
17. Pipinos II, Judge AR, Selsby JT, et al. The myopathy of peripheral arterial occlusive disease: Part 2. Oxidative stress, neuropathy, and shift in muscle fiber type. Vasc Endovascular Surg. 2008 ; 42 (2). 101-112
18. Gardner AW, Parker DE, Montgomery PS, Scott KJ, Blevins SM. Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial. Circulation. 2011 ; 123 (5). 491-498
19. Lohman TC, Roche AF, Marubini E Anthropometric Standardization Reference Manual. Champaign, IL: Human Kinetics Books ; 1988: 39-70.
20. Hiatt WR, Marshall JA, Baxter J, et al. Diagnostic methods for peripheral arterial disease in the San Luis Valley Diabetes Study. J Clin Epidemiol. 1990 ; 43 (6). 597-606
21. Torres JL, Ridker PM. High sensitivity C-reactive protein in clinical practice. Am Heart Hosp J. 2003 ; 1 (3). 207-211
22. Gardner AW. Reliability of transcutaneous oximeter electrode heating power during exercise in patients with intermittent claudication. Angiology. 1997 ; 48 (3). 229-235
23. Feinberg RL, Gregory RT, Wheeler JR, et al. The ischemic window: a method for the objective quantitation of the training effect in exercise therapy for intermittent claudication. J Vasc Surg. 1992 ; 16 (2). 244-250
24. Gardner AW, Montgomery PS, Scott KJ, Afaq A, Blevins SM. Patterns of ambulatory activity in subjects with and without intermittent claudication. J Vasc Surg. 2007 ; 46 (6). 1208-1214
25. Ford ES. Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults. Epidemiology. 2002 ; 13 (5). 561-568
26. Lavie CJ, Church TS, Milani RV, Earnest CP. Impact of physical activity, cardiorespiratory fitness, and exercise training on markers of inflammation. J Cardiopulm Rehabil Prev. 2011 ; 31 (3). 137-145
27. Aguilar EM, Miralles Jde H, Gonzalez AF, Casariego CV, Moreno SB, Garcia FA.. In vivo confirmation of the role of statins in reducing nitric oxide and C-reactive protein levels in peripheral arterial disease. Eur J Vasc Endovasc Surg. 2009 ; 37 (4). 443-447
28. McDermott MM, Guralnik JM, Greenland P, et al. Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease. Circulation. 2003 ; 107 (5). 757-761
29. Mohler ER, Hiatt WR, Creager MA. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. Circulation. 2003 ; 108 (12). 1481-1486